Skip to main content
UHSUniversal Health Services, Inc.Hold6.1·$158.33+5.15%
HoldModerate Confidence
Investment thesis

Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.

Thesis pillars

  • Deep Value Forward Pe At 5xStable
  • Strong Earnings Beat With Analyst UpsideStable
  • Confirmed Downtrend Death Cross BlockStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

Recovery setup · Catalyst-Driven edge

HoldModerate Confidence

Healthcare · Medical Care Facilities

Hold if already holding. Not a fresh buy at $158.33, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -2.4%/30d (confirmed downtrend).

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from... Read more

$158.33+21.5% A.UpsideScore 6.1/10#3 of 36 Medical Care Facilities
QualityF-score8 / 9FCF yield6.79%
IncomeYield0.51%(5y avg 0.51%)Payout3.34%sustainable
Stop $150.43Target $192.44(analyst − 10%)A.R:R 1.9:1
Analyst target$213.82+35.0%17 analysts
$192.44our TP
$158.33price
$213.82mean
$310

Hold if already holding. Not a fresh buy at $158.33, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -2.4%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 72. Maintain position. Not compelling to add more. Score 6.1/10, moderate confidence.

Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 24d clear, semi cycle peak clear, materials cycle peak clear). Suitability: moderate.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Jul 27, 202624d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Margin of safety: 56%
Risks
Below 200-MA, MA slope -2.4%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)6.6
P/E (Fwd)6.3
Mkt Cap$9.6B
EV/EBITDA5.5
Profit Mgn8.6%
ROE21.4%
Rev Growth9.6%
Beta1.07
Dividend0.51%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.23bearish
IV46%normal

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada: We own 10 inpatient acute care hospitals ... these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas: We own 7 inpatient acute care hospitals ... these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California: We own 5 inpatient acute care hospitals ... these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024'

Material Events(8-K, last 90d)

  • 2026-05-21Item 5.02MEDIUM
    Matthew J. Peterson, EVP and President, Behavioral Health, resigned effective June 19, 2026, to pursue an external career opportunity. CEO Marc D. Miller assumes interim responsibilities for the Behavioral Health Care Division; search for permanent replacement underway. No disagreement cited.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025. Routine compensatory arrangement; no departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
1.5
52w Position
2.9
Gap
5.0
GatesDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 6.8>=5.5A.R:R 1.9 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 24d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
72 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $140.08Resistance $161.47

Price Targets

$150
$192
A.Upside+21.5%
A.R:R1.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Analyst Consensus

Analysts26
Consensus3.5/5
Avg Target$214

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-27 (24d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Hold if already holding. Not a fresh buy at $158.33, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -2.4%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 72. Maintain position. Not compelling to add more. Target $192.44 (+21.5%), stop $150.43 (−5.3%), A.R:R 1.9:1. Score 6.1/10, moderate confidence.

What is the UHS stock price target?

Take-profit target: $192.44 (+21.5% upside). Target $192.44 (+21.5%), stop $150.43 (−5.3%), A.R:R 1.9:1. Stop-loss: $150.43.

What are the risks of investing in UHS?

Below 200-MA, MA slope -2.4%/30d (confirmed downtrend).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 6.6 (forward 6.3). TrendMatrix value score: 8.6/10. Verdict: Hold.

What do analysts say about UHS?

26 analysts cover UHS with a consensus score of 3.5/5. Average price target: $214.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers...

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from Medicare, Medicaid, and private insurers, with acute care generating approximately 57% of consolidated net revenues and behavioral health approximately 43%; U.K. operations contributed approximately $1.0 billion in 2025.

Related stocks: NUTX (Nutex Health Inc.) · THC (Tenet Healthcare Corporation) · ARDT (Ardent Health, Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · ASTH (Astrana Health Inc.)
Home Stocks UHS

Latest news

Latest News

MarketWatch74d ago
Yahoo Finance75d ago
Yahoo Finance75d agoEarnings
TradingKey19d ago
AD HOC NEWS19d agoAnalyst
Sahm25d ago
The Globe and Mail75d agoEarnings
TradingView76d agoEarnings
AD HOC NEWS19d agoEarnings
AD HOC NEWS20d ago
Yahoo Finance27d ago
Newsline.com27d agoEarnings
Insider Monkey25d agoAnalyst
TMX Newsfile25d agoLegal
AD HOC NEWS32d ago
The Globe and Mail71d agoEarnings
AD HOC NEWS78d ago
Newsline.com22d ago
HarianBasis.co28d ago
Yahoo Finance28d ago
Loading more...